These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28381537)

  • 21. Usefulness of
    Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
    J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis.
    Knipe RS; Spinney JJ; Abe EA; Probst CK; Franklin A; Logue A; Giacona F; Drummond M; Griffith J; Brazee PL; Hariri LP; Montesi SB; Black KE; Hla T; Kuo A; Cartier A; Engelbrecht E; Christoffersen C; Shea BS; Tager AM; Medoff BD
    Am J Respir Cell Mol Biol; 2022 Jan; 66(1):38-52. PubMed ID: 34343038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
    Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
    Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor.
    Hansen NU; Karsdal MA; Brockbank S; Cruwys S; Rønnow S; Leeming DJ
    Respir Res; 2016 Jul; 17(1):76. PubMed ID: 27411390
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Wahsner J; Désogère P; Abston E; Graham-O'Regan KA; Wang J; Rotile NJ; Schirmer MD; Santos Ferreira DD; Sui J; Fuchs BC; Lanuti M; Caravan P
    J Am Chem Soc; 2019 Apr; 141(14):5593-5596. PubMed ID: 30908032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of CYTL1 attenuates bleomycin-induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF-β/CCN2 axis.
    Wang Y; Liu C; Xie Y; Li X
    Clin Exp Pharmacol Physiol; 2024 Sep; 51(9):e13913. PubMed ID: 39103233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGC-1α regulates endoplasmic reticulum stress in IPF-derived fibroblasts.
    Xu Q; Liu H; Ding Shiwen Fan X; Lv W; Jiang Y; Liang Y; Xu H; Dai J
    Int Immunopharmacol; 2024 Sep; 138():112514. PubMed ID: 38943974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of quercetin in ameliorating bleomycin-induced pulmonary fibrosis: insights into autophagy and the SIRT1/AMPK signaling pathway.
    Li Z; Jiao Y; Wu Z; Liu H; Li Y; Cai Y; Wei W; Cao F
    Mol Biol Rep; 2024 Jul; 51(1):795. PubMed ID: 39001907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
    Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
    Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
    [No Abstract]   [Full Text] [Related]  

  • 38. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
    Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
    Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
    Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
    BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.